September 29, 2011
Santen Pharmaceutical announced on September 28 the acquisition of French biopharmaceutical venture Novagali Pharma. Santen entered into a share purchase agreement on September 27 obtaining 50.55% of Novagali’s outstanding stock and will launch a tender offer for the remaining shares,...read more